sarpogrelate has been researched along with Pain in 4 studies
sarpogrelate: structure given in first source
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined." | 7.73 | Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005) |
| "Sarpogrelate hydrochloride, a selective 5-hydroxytryptamine 2A antagonist, is a widely used antiplatelet agent for the treatment of peripheral arterial disease (PAD)." | 5.22 | Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study. ( Ahn, YK; Chae, IH; Chang, KY; Cho, BR; Cho, DK; Choi, D; Choi, S; Chun, K; Han, KR; Hong, BK; Jin, HY; Kang, W; Kim, DI; Kim, DW; Kim, SH; Kim, YJ; Lee, HC; Lee, JW; Lee, NH; Lee, S; Lee, SR; Park, CG; Pyun, W; Shin, JH; Yu, CW, 2016) |
| "The effects of intrathecally and systemically administered 5-hydroxytriptamine (5-HT)(2A) receptor antagonist, sarpogrelate on acute thermal or formalin induced pain were examined." | 3.73 | Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain. ( Nishiyama, T, 2005) |
| "Sarpogrelate was administered intraperitoneally, locally (subcutaneously at the formalin test site) or intrathecally 10 min before formalin injection." | 1.31 | Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral. ( Goto, F; Ishizaki, K; Obata, H; Saito, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusakari, Y | 1 |
| Yamasaki, K | 1 |
| Aiba, S | 1 |
| Lee, HC | 1 |
| Lee, SR | 1 |
| Han, KR | 1 |
| Yu, CW | 1 |
| Park, CG | 1 |
| Ahn, YK | 1 |
| Jin, HY | 1 |
| Kim, DW | 1 |
| Cho, DK | 1 |
| Choi, S | 1 |
| Kim, SH | 1 |
| Chang, KY | 1 |
| Lee, S | 1 |
| Pyun, W | 1 |
| Lee, NH | 1 |
| Kang, W | 1 |
| Hong, BK | 1 |
| Cho, BR | 1 |
| Chae, IH | 1 |
| Shin, JH | 1 |
| Chun, K | 1 |
| Kim, DI | 1 |
| Lee, JW | 1 |
| Kim, YJ | 1 |
| Choi, D | 1 |
| Nishiyama, T | 1 |
| Obata, H | 1 |
| Saito, S | 1 |
| Ishizaki, K | 1 |
| Goto, F | 1 |
1 trial available for sarpogrelate and Pain
| Article | Year |
|---|---|
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical Study.
Topics: Aged; Arteries; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Peri | 2016 |
3 other studies available for sarpogrelate and Pain
| Article | Year |
|---|---|
Painful macules of hand cholesterol crystal embolization successfully treated with oral corticosteroid, statin, and sarpogrelate.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged, 80 and over; Cholesterol; Crystallization; Drug | 2014 |
Effects of a 5-HT2A receptor antagonist, sarpogrelate on thermal or inflammatory pain.
Topics: Analgesics; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation; | 2005 |
Antinociception in rat by sarpogrelate, a selective 5-HT(2A) receptor antagonist, is peripheral.
Topics: Analgesics; Animals; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Receptors, Serotonin; Recepto | 2000 |